Summary by Moomoo AI
On 21 March 2024, under Rule 22 of the Hong Kong Code of Companies Acquisition and Mergers, Yichang Dongguang Changjiang Pharmaceutical Co., Ltd. (Dongsun Changjiang Pharmaceuticals) entered into a privatized transaction. CICC Financial Trading Limited conducted related securities transactions on 20 March 2024, including the purchase and sale of a total of 240,000 equity swap class securities. The total amount paid at the time of purchase was $2,572,418.93, with a maximum price of $10.7184 per share; the total amount collected at the time of sale was $2,579,318.28, with a maximum price of $10.7472 per share. The transaction was conducted by CICC Financial Trading Limited on its own account and in connection with the contracting party, which is an exempt self-dealing seller.